Shopping Cart
- Remove All
- Your shopping cart is currently empty
Geptanolimab (CBT-501), a humanized IgG4κ monoclonal antibody targeting PD-1 (Programmed Death-1), functions by competitively inhibiting the interaction between PD-L1/L2 and PD-1, thereby possessing potential use in cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Geptanolimab (CBT-501), a humanized IgG4κ monoclonal antibody targeting PD-1 (Programmed Death-1), functions by competitively inhibiting the interaction between PD-L1/L2 and PD-1, thereby possessing potential use in cancer research [1]. |
Cas No. | 2348469-43-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.